Aging and sexuality: how much do gynecologists know and care?

Enhanced knowledge and healthy attitudes toward aging sexuality can help promote the perception that full sexual expression is part of the entire extent of adulthood. We sought to determine gynecologists' knowledge and attitude regarding sexuality in older women. A total of 141 gynecologists in five hospitals responded to the survey: Aging Sexual Attitude and Knowledge Scale (ASKAS). No correlation was found between respondents' knowledge and attitude (r = .06, p = .54); no correlation found between respondents' age and knowledge (r = .20, p = .02), but 20% of the variance in attitude could be explained by age (beta 0.20, p = .02). Neither gender, ethnicity, level of training, nor hospital location demonstrated a significant correlation to either knowledge or attitude scores.

Can myometrial electrical activity identify patients in preterm labor?

OBJECTIVE: The objective of the study was to determine whether myometrial electrical activity can differentiate false from true preterm labor. STUDY DESIGN: Electrical uterine myography (EUM) was measured prospectively on 87 women, gestational age less than 35 weeks. The period between contractions, power of contraction peaks and movement of center of electrical activity (RMS), was used to develop an index score (1-5) for prediction of preterm delivery (PTD) within 14 days of the test. The score was compared with fetal fibronectin (fFN) and cervical length (CL). RESULTS: Patients delivering within 14 days from testing showed a higher index and mean RMS (P = .000). No patients with EUM index scores of 1-2 delivered in this time frame. Combining EUM with CL or fFN increased predictability. Logistic regression revealed that history of PTD and EUM index had 4- to 5-fold increased risk for PTD. Gestational age at testing, body mass index, fFN, and CL were nonsignificant contributors to PTD risk. CONCLUSION: Measuring myometrial electrical activity may enhance identification of patients in true premature labor.

Gestational diabetes: maternal weight gain in relation to fetal growth, treatment modality, BMI and glycemic control.

OBJECTIVES: We sought to determine the impact of maternal weight gain on fetal growth in gestational diabetes (GDM) in relation to treatment modality, body mass index (BMI) and glycemic control. STUDY DESIGN: Two thousand four hundred fifty-four GDMs were evaluated. Obesity was defined as BMI >29; good glycemic control ≤ 100 mg/dl; maternal age < and >30 years; parity ± 1; large for gestational age (LGA) >90th percentile and small for gestational age (SGA) <10th percentile. RESULTS: SGA rates were similar in all groups. Obese/overweight diet-treated women in glycemic control showed a four-fold higher rate of LGA compared to insulin-treated women. A 36-lb weight gain in insulin-treated patients had a six-fold higher risk. In poor glycemic control, LGA rates were higher in all BMI/weight gain categories. Logistic regressions for LGA/SGA revealed that level of glycemia, weight gain, parity, obesity and treatment (for LGA only) were significant. CONCLUSION: Different thresholds used for different maternal BMI categories in addition to the achievement of glycemic control and pharmacological therapy will enhance pregnancy outcome.

Maternal and neonatal outcomes in early glucose tolerance testing in an obstetric population in New York city.

OBJECTIVE: Women with risk factors for diabetes are screened early in pregnancy. At our institution we obtain a GCT (glucose challenge test) at first prenatal visit. We sought to compare pregnancy outcomes in women who were diagnosed with GDM early in pregnancy with those diagnosed at the standard 24-28 weeks' gestation. METHODS: An inner city population receiving prenatal care from August 2003 to May 2007 participated in the study. Patients were screened during the first trimester when able (group 1) or during the standard 24-28 weeks' gestation (group 2). Patient demographics, maternal and neonatal outcome data were collected and analyzed. RESULTS: Of 340 GDM patients identified, 99 were diagnosed early and 241 at the standard time. Eighty per cent of group 2 were treated with diet alone and 20% required pharmacological therapy. Fifty per cent of group 1 were treated with diet and 45% with pharmacological therapy (P<0.001). Comparison between the early and late diagnosis groups for preterm delivery and hypertensive disorders were statistically non-significant. Cesarean delivery was 45% in group 1 and 24% in group 2. Both macrosomia (13% vs. 6%) and large-for-gestational-age (18% vs. 6%) was statistically higher in the early GTT group. CONCLUSION: The adverse perinatal outcome is significantly higher in the early diagnosis group despite early identification and management implying greater severity of GDM.

GDM women in good glycemic control: which meal-related measure enhances fetal well-being?

OBJECTIVE: To determine which meal-related glucose measure maximizes perinatal outcome in gestational diabetes mellitus (GDM) women who have achieved established levels of glycemic control. METHODS: Two thousand two hundred and ninety-eight GDM women were stratified by meal-related blood glucose measures: fasting (<95 mg/dL); pre-meal (< or =90 mg/dL); 2-h post-meal (< or =120 mg/dL); mean (< or =100 mg/dL). The rates of unidentified adverse outcome for composite outcome, neonatal intensive care unit (NICU), metabolic and respiratory complications and cesarean section delivery within each meal-related glucose threshold were calculated. RESULTS: Overall, 25-69% of large-for-gestational-age (LGA)/macrosomic infants were not identified within the recommended meal-related glucose threshold measurements. The lowest rates of unidentified morbidity were found in the pre-meal and mean blood glucose categories while the highest rates were in the post-meal category despite subjects achieving recommended levels of glycemic control. The increased rate of LGA/macrosomia within 10 mg/dL increments for each meal-related glucose category revealed that regardless of the meal-related category, the rate of LGA was significantly higher (15-25%). Logistic regressions (dependent variable= composite outcome or LGA) showed that mean blood glucose was the only significant contributor. CONCLUSION: Currently recommended meal-related glucose measures do not preclude adverse fetal outcome.

Gestational diabetes: the consequences of not treating.

OBJECTIVE: Untreated gestational diabetes mellitus carries significant risks of perinatal morbidity at all severity levels; treatment will enhance outcome. STUDY DESIGN: A matched control of 555 gravidas, gestational diabetes mellitus diagnosed after 37 weeks, were compared with 1110 subjects treated for gestational diabetes mellitus and 1110 nondiabetic subjects matched from the same delivery year for obesity, parity, ethnicity, and gestational age at delivery. The nondiabetic subjects and those not treated for gestational diabetes mellitus were matched for prenatal visits. RESULTS: A composite adverse outcome was 59% for untreated, 18% for treated, and 11% for nondiabetic subjects. A 2- to 4-fold increase in metabolic complications and macrosomia/large for gestational age was found in the untreated group with no difference between nondiabetic and treated subjects. Comparison of maternal size, parity, and disease severity revealed a 2- to 3-fold higher morbidity rate for the untreated groups, compared with the other groups. CONCLUSION: Untreated gestational diabetes mellitus carries significant risks for perinatal morbidity in all disease severity levels. Timely and effective treatment may substantially improve outcome.